Loading insider details...
Latest Form 4 (Oct 28, 2026): Grant/Award of 18,000 CRSP shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 28, 2026 | CRISPR Therapeutics AG (CRSP) | Grant/Award | 18,000 | n/a |
| Oct 15, 2026 | CRISPR Therapeutics AG (CRSP) | Exercise/Conversion | 2,113 | n/a |
| Oct 8, 2026 | CRISPR Therapeutics AG (CRSP) | Exercise/Conversion | 1,990 | $27.1K |
| Sep 24, 2026 | CRISPR Therapeutics AG (CRSP) | Exercise/Conversion | 10,400 | $141.6K |
| Jun 2, 2026 | CRISPR Therapeutics AG (CRSP) | Grant/Award | 17,000 | n/a |
| Mar 24, 2026 | CRISPR Therapeutics AG (CRSP) | Exercise/Conversion | 6,250 | n/a |
| Mar 17, 2026 | CRISPR Therapeutics AG (CRSP) | Exercise/Conversion | 6,875 | n/a |
| Mar 12, 2026 | CRISPR Therapeutics AG (CRSP) | Exercise/Conversion | 5,500 | n/a |
| Feb 20, 2026 | CRISPR Therapeutics AG (CRSP) | Exercise/Conversion | 3,825 | n/a |
| Oct 15, 2025 | CRISPR Therapeutics AG (CRSP) | Exercise/Conversion | 2,114 | n/a |